Mylan

Andrew G. Cuneo has been named vice president of global business development at Mylan, Inc. Mr. Cuneo is responsible for coordinating Mylan’s global business development and strategic efforts in close alignment with the company’s executive leadership team.

He joins Mylan from Merrill Lynch, a financial management and advisory firm, where he worked for more than a decade on strategic advisory and capital markets transactions, primarily in the health care sector. Most recently he served as a director in its Global Healthcare Investment Banking group.

Mylan’s vice chairman and chief executive office Robert J. Coury remarked, “Drew brings a wealth of experience in the pharmaceutical, biotechnology and health care sectors. His familiarity with our industry – and in particular with Mylan given his and Merrill Lynch’s active role with the company during the past five years – makes him ideally suited to support the company’s continued growth.”

“Mylan has emerged as one of the industry’s best run and most progressive pharmaceutical franchises,” said Mr. Cuneo. “I’m excited to be able to continue participating and to further contribute to the development and execution of its plans for profitable commercial expansion.”